KK
DAWN

KLP Kapitalforvaltning’s Day One Biopharmaceuticals DAWN Stock Holding History

KLP Kapitalforvaltning’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,400
Closed -$144K – 2171
2025
Q4 		$144K Buy
15,400
+3,600
+31% +$30.1K ﹤0.01% 1960
2025
Q3 		$83.2K Hold
11,800
– – ﹤0.01% 2096
2025
Q2 		$76.7K Hold
11,800
– – ﹤0.01% 2105
2025
Q1 		$93.6K Hold
11,800
– – ﹤0.01% 2049
2024
Q4 		$150K Buy
+11,800
New +$164K ﹤0.01% 1937

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KLP Kapitalforvaltning's DAWN Position: Q1 2026 in Review

KLP Kapitalforvaltning sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 15,400 shares — an estimated $144K sold.

KLP Kapitalforvaltning first reported a position in DAWN in Q4 2024 and held it in 5 quarters. The position peaked at $150K in Q4 2024. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • KLP Kapitalforvaltning reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 15,400 Day One Biopharmaceuticals shares in Q1 2026, an estimated $144K.
  • KLP Kapitalforvaltning first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 5 quarters.
  • KLP Kapitalforvaltning's Day One Biopharmaceuticals position peaked at $150K in Q4 2024.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.